Cusabio Polyclonal Antibodies
Phospho-MET (Tyr1234) Antibody | CSB-PA890092
- SKU:
- CSB-PA890092
- Availability:
- 3 to 7 Working Days
- Size:
- 100ul
Description
Phospho-MET (Tyr1234) Antibody | CSB-PA890092 | Cusabio
Phospho-MET (Tyr1234) Antibody is Available at Gentaur Genprice with the fastest delivery.
Online Order Payment is possible or send quotation to info@gentaur.com.
Product Type: Polyclonal Antibody
Target Names: MET
Aliases: HGF receptor; receptor; Met proto-oncogene tyrosine kinase; c-met; kinase Met
Background: Receptor for hepatocyte growth factor and scatter factor. Has a tyrosine-protein kinase activity. Functions in cell proliferation, scattering, morphogenesis and survival.
Gherardi E. et al. (2003) .Proc Natl Acad Sci U S A. 100 (21) : 12039-12044.
Shiu SH. et al. (2001) Proc Natl Acad Sci U S A. 98 (19) : 10763-10768.
Hughes AL. et al. (2001) Genome Res. 11 (5) : 771-780.
Onuchic LF. et al. (2002) Am J Hum Genet. 70 (5) : 1305-1317.
Isotype: IgG
Conjugate: Non-conjugated
Clonality: Polyclonal
Uniport ID: P08581
Host Species: Rabbit
Species Reactivity: Human, Mouse, Rat
Immunogen: Peptide sequence around phosphorylation site of tyrosine 1234 (K-E-Y (p) -Y-S) derived from Human Met.
Immunogen Species: Human
Applications: ELISA, WB
Tested Applications: ELISA, WB;WB:1:500-1:1000
Purification Method: Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide.
Dilution Ratio1: ELISA:1:2000-1:10000
Dilution Ratio2: WB:1:500-1:1000
Dilution Ratio3:
Dilution Ratio4:
Dilution Ratio5:
Dilution Ratio6:
Buffer: Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Form: liquid
Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Initial Research Areas: Signal Transduction
Research Areas: Epigenetics & Nuclear Signaling;Cancer;Signal transduction